| 000 | 01754 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514005638.0 | ||
| 264 | 0 | _c20010927 | |
| 008 | 200109s 0 0 eng d | ||
| 022 | _a0360-3016 | ||
| 024 | 7 |
_a10.1016/s0360-3016(01)01626-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGirinsky, T | |
| 245 | 0 | 0 |
_aA high and sustained response rate in refractory or relapsing low-grade lymphoma masses after low-dose radiation: analysis of predictive parameters of response to treatment. _h[electronic resource] |
| 260 |
_bInternational journal of radiation oncology, biology, physics _cSep 2001 |
||
| 300 |
_a148-55 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aConfidence Intervals |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRadiotherapy Dosage |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aGuillot-Vals, D | |
| 700 | 1 | _aKoscielny, S | |
| 700 | 1 | _aCosset, J M | |
| 700 | 1 | _aGanem, G | |
| 700 | 1 | _aCarde, P | |
| 700 | 1 | _aMonhonval, M | |
| 700 | 1 | _aPereira, R | |
| 700 | 1 | _aBosq, J | |
| 700 | 1 | _aRibrag, V | |
| 700 | 1 | _aVantelon, J M | |
| 700 | 1 | _aMunck, J N | |
| 773 | 0 |
_tInternational journal of radiation oncology, biology, physics _gvol. 51 _gno. 1 _gp. 148-55 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0360-3016(01)01626-1 _zAvailable from publisher's website |
| 999 |
_c11441327 _d11441327 |
||